Clinical Trial Update: Short Course Radiation Therapy With Proton or Photon Beam Capecitabine and Hydroxychloroquine for Resectable Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial investigating short-course radiation therapy with proton or photon beam, capecitabine, and hydroxychloroquine for resectable pancreatic cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Hydroxychloroquine (hydroxychloroquine)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Pancreatic Cancer | Phase 2 | Status: UNKNOWN